Search results

Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.

Participants undertook IAEA training hosted by Macquarie University and ANSTO on use of radionuclides for soil and water investigations.

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

A selection of research highlights, instrument news and technical developments for scientists.

You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG). 

By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.

Supporting healthcare professionals in Australia with easy-to-access resources related to ANSTO’s Gentech® Generator.

Highlights of the Energy Materials Project.